Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
-
- J. Kuhle
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- D. Leppert
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- A. Petzold
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- A. Regeniter
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- C. Schindler
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- M. Mehling
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- D.C. Anthony
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- L. Kappos
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
-
- R.L.P. Lindberg
- From Clinical Neuroimmunology, Departments of Biomedicine and Neurology (J.K., D.L., M.M., L.K., R.L.P.L.), Laboratory Medicine (A.R.), and Institute for Social and Preventive Medicine (C.S.), University Hospital Basel, Basel, Switzerland; UCL Institute of Neurology (A.P.), Department of Neuroimmunology, Queen Square, London, UK; Department of Neurology (A.P.), Free University Medical Center, Amsterdam, the Netherlands; and Department of Pharmacology (D.C.A.), University of Oxford, UK.
収録刊行物
-
- Neurology
-
Neurology 76 (14), 1206-1213, 2011-04-05
Ovid Technologies (Wolters Kluwer Health)
